Singapore markets closed

Straits Times Index
3,331.70
+5.42(+0.16%)
S&P 500
5,464.09
-5.21(-0.10%)
Dow
39,045.44
-66.72(-0.17%)
Nasdaq
17,758.11
+40.46(+0.23%)
Bitcoin USD
61,779.82
+66.72(+0.11%)
CMC Crypto 200
1,276.54
-7.24(-0.56%)

ITCI Aug 2024 55.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.3400

0.0000

(0.00%)

As of 10:47AM EDT. Market open.

Zacks
Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe
Intra-Cellular (ITCI) is witnessing strong Caplyta sales, driven by an increasing prescription rate. However, the company is heavily dependent on Caplyta sales for growth, which is a concern.
Zacks
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Intra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight following pipeline and regulatory updates, respectively.
Zacks
Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals
Intra-Cellular (ITCI) gains 10% after achieving key goals in the second late-stage study evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of MDD.